132 related articles for article (PubMed ID: 10640903)
21. Protein-bound polysaccharide PSK inhibits tumor invasiveness by down-regulation of TGF-beta1 and MMPs.
Zhang H; Morisaki T; Matsunaga H; Sato N; Uchiyama A; Hashizume K; Nagumo F; Tadano J; Katano M
Clin Exp Metastasis; 2000; 18(4):343-52. PubMed ID: 11448066
[TBL] [Abstract][Full Text] [Related]
22. Fisetin inhibits migration and invasion of human cervical cancer cells by down-regulating urokinase plasminogen activator expression through suppressing the p38 MAPK-dependent NF-κB signaling pathway.
Chou RH; Hsieh SC; Yu YL; Huang MH; Huang YC; Hsieh YH
PLoS One; 2013; 8(8):e71983. PubMed ID: 23940799
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor-beta1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity.
Farina AR; Coppa A; Tiberio A; Tacconelli A; Turco A; Colletta G; Gulino A; Mackay AR
Int J Cancer; 1998 Mar; 75(5):721-30. PubMed ID: 9495240
[TBL] [Abstract][Full Text] [Related]
24. Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and matrigel invasion.
Festuccia C; Giunciuglio D; Guerra F; Villanova I; Angelucci A; Manduca P; Teti A; Albini A; Bologna M
Oncol Res; 1999; 11(1):17-31. PubMed ID: 10451028
[TBL] [Abstract][Full Text] [Related]
25. [EGF receptor and effects of EGF on growth and tumor marker secretion in uterine cervical cancer cells].
Ueda M; Okamoto Y; Yamada T; Misaki O; Tsurunaga T; Iwai E; Yanagawa Y; Ueki M; Sugimoto O
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Nov; 40(11):1700-6. PubMed ID: 3266224
[TBL] [Abstract][Full Text] [Related]
26. 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells.
Koli K; Keski-Oja J
Cell Growth Differ; 2000 Apr; 11(4):221-9. PubMed ID: 10775039
[TBL] [Abstract][Full Text] [Related]
27. Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells.
Kawamata H; Azuma M; Kameyama S; Nan L; Oyasu R
Cell Growth Differ; 1992 Nov; 3(11):819-25. PubMed ID: 1467309
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-1 beta and transforming growth factor-beta 3 cooperate to activate matrix metalloproteinase expression and invasiveness in A549 lung adenocarcinoma cells.
Petrella BL; Armstrong DA; Vincenti MP
Cancer Lett; 2012 Dec; 325(2):220-6. PubMed ID: 22796605
[TBL] [Abstract][Full Text] [Related]
29. Induction of urinary plasminogen activator by retinoic acid results in increased invasiveness of human prostate cancer cells PC-3.
Liu DF; Rabbani SA
Prostate; 1995 Nov; 27(5):269-76. PubMed ID: 7479394
[TBL] [Abstract][Full Text] [Related]
30. HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity.
Trusolino L; Cavassa S; Angelini P; Andó M; Bertotti A; Comoglio PM; Boccaccio C
FASEB J; 2000 Aug; 14(11):1629-40. PubMed ID: 10928998
[TBL] [Abstract][Full Text] [Related]
31. Effects of epidermal growth factor on invasiveness through the extracellular matrix in high- and low-metastatic clones of RCT sarcoma in vitro.
Yudoh K; Matsui H; Kanamori M; Maeda A; Ohmori K; Tsuji H
Jpn J Cancer Res; 1994 Jan; 85(1):63-71. PubMed ID: 8106290
[TBL] [Abstract][Full Text] [Related]
32. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.
Fujiuchi Y; Nagakawa O; Murakami K; Fuse H; Saiki I
Oncol Rep; 2003; 10(4):1001-6. PubMed ID: 12792760
[TBL] [Abstract][Full Text] [Related]
33. TGF-beta-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system.
Ellenrieder V; Hendler SF; Ruhland C; Boeck W; Adler G; Gress TM
Int J Cancer; 2001 Jul; 93(2):204-11. PubMed ID: 11410867
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor (EGF) increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704.
Price JT; Wilson HM; Haites NE
Eur J Cancer; 1996 Oct; 32A(11):1977-82. PubMed ID: 8943684
[TBL] [Abstract][Full Text] [Related]
35. EGF induces the expression of matrilysin in the human prostate adenocarcinoma cell line, LNCaP.
Sundareshan P; Nagle RB; Bowden GT
Prostate; 1999 Aug; 40(3):159-66. PubMed ID: 10398277
[TBL] [Abstract][Full Text] [Related]
36. Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity.
Wang FQ; Ariztia EV; Boyd LR; Horton FR; Smicun Y; Hetherington JA; Smith PJ; Fishman DA
Gynecol Oncol; 2010 Apr; 117(1):88-95. PubMed ID: 20056268
[TBL] [Abstract][Full Text] [Related]
37. Synergistic enhancement of EGF, but not HGF, stimulated hepatocyte motility by TGF-beta 1 in vitro.
Stolz DB; Michalopoulos GK
J Cell Physiol; 1997 Jan; 170(1):57-68. PubMed ID: 9012785
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells.
Hauck CR; Sieg DJ; Hsia DA; Loftus JC; Gaarde WA; Monia BP; Schlaepfer DD
Cancer Res; 2001 Oct; 61(19):7079-90. PubMed ID: 11585739
[TBL] [Abstract][Full Text] [Related]
39. EGF and TGF alpha influence in vitro lung development by the induction of matrix-degrading metalloproteinases.
Ganser GL; Stricklin GP; Matrisian LM
Int J Dev Biol; 1991 Dec; 35(4):453-61. PubMed ID: 1801870
[TBL] [Abstract][Full Text] [Related]
40. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.
Tuck AB; Arsenault DM; O'Malley FP; Hota C; Ling MC; Wilson SM; Chambers AF
Oncogene; 1999 Jul; 18(29):4237-46. PubMed ID: 10435636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
